These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11451738)

  • 1. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
    Pepper MS
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular proteolysis and angiogenesis.
    Pepper MS
    Thromb Haemost; 2001 Jul; 86(1):346-55. PubMed ID: 11487024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the pericellular fibrinolytic system in angiogenesis.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen activators and matrix metalloproteinases in angiogenesis.
    Mignatti P; Rifkin DB
    Enzyme Protein; 1996; 49(1-3):117-37. PubMed ID: 8797002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of the plasminogen/plasmin system.
    Lijnen HR
    Int J Clin Lab Res; 1996; 26(1):1-6. PubMed ID: 8739849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.
    van Hinsbergh VW; Koolwijk P; Hanemaaijer R
    EXS; 1997; 79():391-411. PubMed ID: 9002228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators and angiogenesis.
    Mignatti P; Rifkin DB
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():33-50. PubMed ID: 8814993
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis.
    Gong R; Rifai A; Tolbert EM; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2003 Dec; 14(12):3047-60. PubMed ID: 14638904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
    Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T
    Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue-type plasminogen activator receptor on these cells.
    Ellis V; Whawell SA
    Blood; 1997 Sep; 90(6):2312-22. PubMed ID: 9310482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH; de Bart AC; Schalken JA; Verheijen JH
    Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
    J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
    Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
    J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.